UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF THE
SECURITIES EXCHANGE ACT OF 1934
For the month of June 2023
Commission File Number: 001-39446
CureVac N.V.
(Exact Name of Registrant as Specified in Its Charter)
Friedrich-Miescher-Strasse 15, 72076
Tübingen, Germany
+49 7071 9883 0
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
| Form 20-F |
x |
Form 40-F | ¨ |
On June 22, 2023, CureVac N.V. (the “Company”) issued a table containing tabulations of the votes cast at the Company’s annual general meeting of shareholders.
The information in this Form 6-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| CUREVAC N.V. | ||
| By: | /s/ Alexander Zehnder | |
| Chief Executive Officer | ||
Date: June 22, 2023
EXHIBIT INDEX
| EXHIBIT NO. | DESCRIPTION | |
| 99.1 | Final Tabulation Table of Votes Cast on the Company’s Annual General Meeting of Shareholders. |
Exhibit 99.1
CureVac N.V., Tübingen, Germany
General Meeting of Shareholders, June 19, 2023
Voting results – Overview
| Agenda Item 3 | Adoption of the annual accounts over the financial year 2022 - accepted | |
| 162.009.808 | Number of shares for which valid votes were cast (= 72.37 % of the registered share capital) | |
| 161.947.876 | Yes votes | 99.99 % of the valid votes cast |
| 14.771 | No votes | 0.0 % of the valid votes cast |
| Agenda Item 5 | Release of managing directors from liability for the exercise of their duties during the financial year 2022 - accepted | |
| 162.009.808 | Number of shares for which valid votes were cast (= 72.37 % of the registered share capital) | |
| 161.888.915 | Yes votes | 99.94 % of the valid votes cast |
| 85.524 | No votes | 0.05 % of the valid votes cast |
| Agenda Item 6 | Release of supervisory directors from liability for the exercise of their duties during the financial year 2022 - accepted | |
| 162.009.828 | Number of shares for which valid votes were cast (= 72.37 % of the registered share capital) | |
| 160.595.409 | Yes votes | 99.19 % of the valid votes cast |
| 1.303.341 | No votes | 0.80 % of the valid votes cast |
| Agenda Item 7 | Appointment of Michael Brosnan as member of the Supervisory Board - accepted | |
| 162.009.808 | Number of shares for which valid votes were cast (= 72.37 % of the registered share capital) | |
| 155.332.945 | Yes votes | 95.88 % of the valid votes cast |
| 6.660.769 | No votes | 4.11 % of the valid votes cast |
| Agenda Item 8 | Appointment of the external auditor for the financial year 2024 - accepted | |
| 162.009.808 | Number of shares for which valid votes were cast (= 72.37 % of the registered share capital) | |
| 161.985.218 | Yes votes | 99.98 % of the valid votes cast |
| 19.534 | No votes | 0.01 % of the valid votes cast |
1